164
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
(www.bloomberg.com)
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
this post was submitted on 31 Oct 2023
164 points (100.0% liked)
Science
13006 readers
2 users here now
Studies, research findings, and interesting tidbits from the ever-expanding scientific world.
Subcommunities on Beehaw:
Be sure to also check out these other Fediverse science communities:
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
I'm waiting for the part where the US insurance companies are discovered using that data en mass to increase premiums and deny coverage.
That's going to be my "I told you so".
That will take a long time, right now analyzing one person's DNA to a point where an insurance company could profit from it costs way more than the extra profits from denying some potentially short-lived clients.
(or an AI based analyzer is already in the works)
Considering prior authorization is predicated on the fact that if they reject enough requests inevitably some people won't fight them, meaning they don't have to pay out, I wouldn't be surprised if they use a slightly better than chance prediction as justification for denying coverage, if they even need an actual excuse to begin with.
I'm old enough that a lot of things that were going to take a long time have come to pass, so I feel confident this will come.
AI and genetics are both moving fairly fast, and insurance is about numbers and probabilities.